Journal of Neurology

, Volume 255, Issue 11, pp 1838–1839 | Cite as

Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer

  • M. Glas
  • M. Stuplich
  • H. Tschampa
  • H. Urbach
  • K. Rasch
  • U. Herrlinger
Letter to the Editors

References

  1. 1.
    Altundag K, Bondy ML, Mirza NQ, et al. (2007) Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer 110:2640–2647CrossRefPubMedGoogle Scholar
  2. 2.
    Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22:3608–3617CrossRefPubMedGoogle Scholar
  3. 3.
    Chamberlain MC. Neoplastic meningitis (2005) J Clin Oncol 23:3605–3613CrossRefPubMedGoogle Scholar
  4. 4.
    Rudnicka H, NiwiKska A, Murawska M (2007) Breast cancer leptomeningeal metastasis – the role of multimodality treatment. J Neurooncol 84:57–62CrossRefPubMedGoogle Scholar
  5. 5.
    Jayson GC, Howell A (1996) Carcinomatous meningitis in solid tumours. Ann Oncol 7:773–786PubMedGoogle Scholar
  6. 6.
    Glantz MJ, Jaeckle KA, Chamberlain MC, et al. (1999) A randomized controlled trial comparing intrathecal sustained- release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5:3394–3402PubMedGoogle Scholar
  7. 7.
    Jaeckle KA, Phuphanich S, Bent MJ, et al. (2001) Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br J Cancer 84:157–163CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • M. Glas
    • 1
  • M. Stuplich
    • 1
  • H. Tschampa
    • 2
  • H. Urbach
    • 2
  • K. Rasch
    • 1
  • U. Herrlinger
    • 1
  1. 1.Clinical Neurooncology Unit, Dept. of NeurologyUniversity of Bonn, Medical CenterBonnGermany
  2. 2.Dept. of RadiologyUniversity of Bonn, Medical CenterBonnGermany

Personalised recommendations